0001883850-22-000054.txt : 20220808
0001883850-22-000054.hdr.sgml : 20220808
20220808161230
ACCESSION NUMBER: 0001883850-22-000054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220804
FILED AS OF DATE: 20220808
DATE AS OF CHANGE: 20220808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN ARTHUR F
CENTRAL INDEX KEY: 0001187443
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 221144500
MAIL ADDRESS:
STREET 1: CITIZENS FINANCIAL GROUP, INC
STREET 2: 600 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-08-04
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001187443
RYAN ARTHUR F
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2022-08-04
5
G
0
2500
0.0
D
19682
D
Common Stock
2022-08-04
4
M
0
3613
482.68
A
23295
D
Common Stock
2022-08-04
4
S
0
4887
620.85
D
18408
D
Common Stock
2022-08-04
4
M
0
4361
374.12
A
22769
D
Common Stock
2022-08-04
4
S
0
4156
621.54
D
18613
D
Common Stock
2022-08-04
4
M
0
2479
380.95
A
21092
D
Common Stock
2022-08-04
4
S
0
1410
622.06
D
19682
D
Non-Qualified Stock Option (right to buy)
374.12
2022-08-04
4
M
0
4361
0.0
D
2030-01-02
Common Stock
4361
0
D
Non-Qualified Stock Option (right to buy)
380.95
2022-08-04
4
M
0
2479
0.0
D
2028-01-02
Common Stock
2479
0
D
Non-Qualified Stock Option (right to buy)
482.68
2022-08-04
4
M
0
3613
0.0
D
2031-01-04
Common Stock
3613
0
D
Represents volume-weighted average price of sales of 4,887 shares of Company stock on August 4, 2022 at prices ranging from $620.16 to $620.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
Represents volume-weighted average price of sales of 4,156 shares of Company stock on August 4, 2022 at prices ranging from $621.00 to $621.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
Represents volume-weighted average price of sales of 1,410 shares of Company stock on August 4, 2022 at prices ranging from $622.00 to $622.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2022 at each separate price.
On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Arthur F. Ryan
2022-08-08